Preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2-and MyD88-dependent signaling pathway

被引:481
作者
Takeuchi, O
Kaufmann, A
Grote, K
Kawai, T
Hoshino, K
Morr, M
Muhlradt, PF
Akira, S
机构
[1] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan
[2] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Osaka, Japan
[3] Univ Marburg, Inst Immunol, D-3550 Marburg, Germany
[4] Gesell Biotechnol Forsch mbH, Immunobiol Res Grp, D-3300 Braunschweig, Germany
关键词
D O I
10.4049/jimmunol.164.2.554
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mycoplasmas and their membranes are potent activators of macrophages, the active principle being Lipoproteins and lipopeptides. Two stereoisomers of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 (MALP-2) differing in the configuration of the lipid moiety were synthesized and compared in their macrophage-activating potential, the R-MALP being >100 times more active than the S-MALP in stimulating the release of cytokines, chemokines, and NO, To assess the role of the Toll-like receptor (TLR) family in mycoplasmal lipopeptide signaling, the MALP-2-mediated responses were analyzed using macrophages from wild-type, TLR2-, TLR4-, and MyD88-deficient mice, TLR2- and MyD88-deficient cells showed severely impaired cytokine productions in response to R- and S-MALP, The MALP-induced activation of intracellular signaling molecules was fully dependent on both TLR2 and MyD88. There was a strong preference for the R-MALP in the recognition by its functional receptor, TLR2.
引用
收藏
页码:554 / 557
页数:4
相关论文
共 30 条
  • [1] Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function
    Adachi, O
    Kawai, T
    Takeda, K
    Matsumoto, M
    Tsutsui, H
    Sakagami, M
    Nakanishi, K
    Akira, S
    [J]. IMMUNITY, 1998, 9 (01) : 143 - 150
  • [2] Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2
    Aliprantis, AO
    Yang, RB
    Mark, MR
    Suggett, S
    Devaux, B
    Radolf, JD
    Klimpel, GR
    Godowski, P
    Zychlinsky, A
    [J]. SCIENCE, 1999, 285 (5428) : 736 - 739
  • [3] Mycoplasmas: Sophisticated, reemerging, and burdened by their notoriety
    Baseman, JB
    Tully, JG
    [J]. EMERGING INFECTIOUS DISEASES, 1997, 3 (01) : 21 - 32
  • [4] Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors
    Brightbill, HD
    Libraty, DH
    Krutzik, SR
    Yang, RB
    Belisle, JT
    Bleharski, JR
    Maitland, M
    Norgard, MV
    Plevy, SE
    Smale, ST
    Brennan, PJ
    Bloom, BR
    Godowski, PJ
    Modlin, RL
    [J]. SCIENCE, 1999, 285 (5428) : 732 - 736
  • [5] Mycoplasmal lipopeptide MALP-2 induces the chemoattractant proteins macrophage inflammatory protein 1α (MIP-1α), monocyte chemoattractant protein 1, and MIP-2 and promotes leukocyte infiltration in mice
    Deiters, U
    Mühlradt, PF
    [J]. INFECTION AND IMMUNITY, 1999, 67 (07) : 3390 - 3398
  • [7] A Mycoplasma fermentans-derived synthetic lipopeptide induces AP-1 and NF-κB activity and cytokine secretion in macrophages via the activation of mitogen-activated protein kinase pathways
    Garcia, J
    Lemercier, B
    Roman-Roman, S
    Rawadi, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (51) : 34391 - 34398
  • [8] Bacterial modulins: A novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis
    Henderson, B
    Poole, S
    Wilson, M
    [J]. MICROBIOLOGICAL REVIEWS, 1996, 60 (02) : 316 - +
  • [9] HERBERT DL, 1994, SPORTS MED STAND MAL, V6, P62
  • [10] Hirschfeld M, 1999, J IMMUNOL, V163, P2382